جستجوی استاد راهنمای دانشگاهی

Professor Christine Lu is a globally recognized academic in clinical pharmacy and pharmacoeconomics, serving as Chair of Clinical Pharmacy at the Sydney Pharmacy School, University of Sydney. She holds a dual appointment at the Northern Sydney Local Health District and has held previous roles at Harvard Medical School and Harvard Pilgrim Health Care Institute. Her expertise spans health policy, genomic medicine, and pharmacoepidemiology, with a focus on optimizing medication use and outcomes in diverse populations. Education & Career: Dr. Lu earned her MSc (Biopharmaceuticals) and PhD from the University of New South Wales and completed postdoctoral training at Harvard Medical School. She transitioned from academic roles in the U.S. to the University of Sydney in 2023. Research Interests: Her work addresses critical issues in healthcare systems, including: Impact of health policies on medication access and outcomes Genomic healthcare (e.g., pharmacogenomics) and ethical implications Quality use of high-cost medicines and biosimilars Real-world evidence generation using linked datasets Her current projects include national analyses of precision medicine and biosimilar utilization in Australia. Publications & Impact: Over 200 peer-reviewed articles reflect her focus on disparities in chronic disease outcomes, pharmacogenetic testing, and AI-driven predictive analytics. Recent work highlights disparities in heart failure mortality among diabetes patients and the utility of genomic testing in pediatric populations. Awards & Recognition: Recipient of the Genomic Innovator Award (NIH, 2020-2025), Robert H. Ebert Career Development Award (Harvard, 2018-2020), and the Caroline Miles Award (University of Oxford, 2016). Grants & Mentorship: Leads postgraduate research scholarships in medicines policy and outcomes research. Current advisees include Harry LE (optimizing psychotropic use in dementia) and Benson YIU (biosimilar utilization analysis). She chairs multidisciplinary teams at the Sydney Pharmacy School and collaborates internationally on implementation science initiatives like the IMPULSS program for Lynch syndrome screening. Labs & Collaborations: Active in translational research through the Sydney Pharmacy School’s Clinical Pharmacy Unit, focusing on real-world data applications and health technology assessment. Collaborates with global networks including ISPOR and the Harvard Club of Australia.

• Health Policy
• Genomics
• Pharmacogenomics
• +۴ مورد دیگر

Dr. Victoria Goss PhD serves as Head of the Early Diagnosis and Translational Group at the University of Southampton, focusing on respiratory and metabolic research with clinical applications. Her work bridges laboratory science and patient care through translational approaches to respiratory disorders. Her research centers on lipid metabolism in respiratory diseases , particularly examining surfactant phospholipid kinetics in ventilated children, cellular phosphatidylcholine dynamics in ARDS, and lipidomic profiling in asthma. Key interests include pediatric pulmonology , asthma stratification , and early diagnostic biomarkers for conditions like pancreatic cancer. Her methodology integrates advanced lipidomics with clinical observational studies to identify treatable traits in chronic respiratory diseases. Analysis of her 10 most recent publications (2018-2024) reveals consistent focus on lipid-based mechanisms across respiratory conditions, with increasing emphasis on translational applications including diagnostic protocols (MecROX, DEPEND studies) and asthma endotyping. Her work frequently employs mass spectrometry lipid profiling and cellular kinetics analysis in both pediatric and adult populations. Current research initiatives include the MecROX study on oxidative stress in ventilated patients and DEPEND study for pancreatic cancer screening. She actively collaborates with European consortia like U-BIOPRED, reflecting her integration within international respiratory research networks.

• Respiratory Medicine
• Lipidomics
• Translational Medicine
• +۳ مورد دیگر

Yuanyuan Gu is an Associate Professor at Macquarie University's Centre for the Health Economy. His expertise spans health economics, aging, choice modeling, and econometrics, with a focus on preferences and decision-making in healthcare systems. He leads the health preference research stream and advises on health technology assessments. He has secured over A$14 million in funding, including a Marie Skłodowska-Curie Fellowship. Education: PhD in Economics (UNSW, 2011), MCom (Hons) in Economics (UNSW), BSc in Statistics (Fudan University). Research Interests include improving healthcare quality through preference analysis, cost-effectiveness studies, and policy-relevant research. Recent projects address aged care financing, patient preferences for treatments, and precision medicine applications. Key Awards: MQBS Research Impact Prize (2023, 2025), Centre for Health Economy Publication Prize (2023). Advising & Grants: Supervises 6 current PhD students (e.g., Zobaida Ahmed Piu on oral contraceptives, Han Cheng on income inequality and health) and advises on PBAC evaluations. Active in editorial roles for PharmacoEconomics and Journal of Hospital Management and Health Policy . Labs/Teams: Collaborates on projects like sensory support interventions for dementia patients and outcomes-based care evaluations for vulnerable populations.

• Health Economics
• Economics of Ageing
• Choice Modelling
• +۷ مورد دیگر

Professor Dawn Alison Coverley is a renowned cell biologist at the University of York, specializing in epigenetic maintenance and cancer-related research. She holds the position of Professor in the Department of Biology and serves as Chief Scientific Officer (CSO) of Cizzle Biotechnology Limited, a spin-out company focused on early cancer detection. Her research explores the role of CIZ1 protein variants in epigenetic stability and their implications in cancer onset and therapy. Education: BSc in Genetics (University of Leicester), PhD in Biochemistry (Cancer Research UK-funded). Postdoctoral training at Cambridge University (1992). Research Interests: Structure/function of the mammalian cell nucleus, DNA replication, epigenetic regulation, and the interplay between epigenetic and genetic instability in cancer. Her work has led to the identification of CIZ1B as a potential biomarker for early-stage lung cancer, with applications in clinical diagnostics. Teaching: Focuses on cancer biology, integrating experimental techniques and conceptual frameworks to foster student innovation. Supervises projects on CIZ1 variants using cell culture, microscopy, and bioinformatics. Awards: Bioscience Yorkshire Enterprise Fellowship (2004), Lister Institute Senior Research Fellowship (2002). Active in collaborative projects, including biomarker development and MRC-funded studies on epigenetic maintenance. Labs/Teams: Principal Investigator of an academic DNA replication lab at York and leads Cizzle Biotech’s biomarker research.

• Epigenetics
• Cancer Biology
• Molecular Biology
• +۳ مورد دیگر

Dr. Micha Sam Brickman Raredon is an Assistant Professor in the Department of Anesthesiology at Yale School of Medicine. He leads the Raredon Laboratory, focused on regenerative lung engineering, systems biology, and bioengineered tissues. His work integrates computational tools like NICHES and Connectome to study cell-cell communication networks in lung tissue. Dr. Raredon holds MD/PhD degrees from Yale and a master's from MIT in Materials Science. His research spans lung vascular networks, fibrosis mechanisms, and translational applications in regenerative medicine. He is affiliated with the Vascular Biology and Therapeutics Program, Program in Translational Biomedicine, and Yale Combined Program in the Biological and Biomedical Sciences (BBS). Education: MD/PhD Yale University (2022/2021), MS Yale Engineering (2020), MPhil Yale (2020), MS MIT (2014), BS Yale & Cambridge (2011). Research Interests: Engineering functional lung tissues, decoding lung microvascular niches, single-cell systems biology, and applying machine learning to tissue regeneration. Key projects include developing algorithms for cell-cell interaction analysis and engineering patient-specific lung tissues. Recent work addresses hypoxia-induced cardiopulmonary damage and fibrotic lung diseases. Publications reflect interdisciplinary focus on lung biology, vascular integrity, and computational methods. Awards include the Draper Fellowship for tissue fabrication innovation and the Yale MD/PhD Thesis Prize. His lab collaborates with leading figures like Drs. Kaminski, Niklason, and Medzhitov. Advising and Grants: Mentors students in translational research. Lab develops ventilator splitting systems for disaster medicine and bioengineered lung models. Active in NIH-funded projects on lung regeneration and fibrosis. Labs/Teams: Raredon Lab at Yale Vascular Biology Program. Collaborations span Yale's Systems Biology, Immunobiology, and Biomedical Engineering departments.

• Regenerative Lung Engineering
• Cell-to-Cell Communication Networks
• Systems Biology
• +۵ مورد دیگر

Nelson LaMarche is an Assistant Professor in the Department of Pathology at Yale School of Medicine and a member of the Cancer Biology Institute within Yale Cancer Center. He earned his Ph.D. in Immunology from Harvard University (2020) under Drs. Michael Brenner and Lydia Lynch, followed by postdoctoral training at Icahn School of Medicine at Mount Sinai (2024) with Dr. Miriam Merad. His research focuses on myeloid-targeted immunotherapies for cancer , investigating how tumors communicate with distant organs to subvert immune responses. Key findings include the discovery of IL-4 signaling in bone marrow driving immunosuppressive myeloid cells in lung cancer, leading to a clinical trial of dupilumab (2024, Nature ). Research Themes : Cancer immunology, tumor microenvironment, myeloid cell biology, metabolic homeostasis, bone marrow-tumor communication Methodologies : High-dimensional patient tissue profiling, mouse models, translational immunotherapy development Current work emphasizes systemic tumor-immune interactions , aiming to identify novel therapeutic targets beyond traditional T cell-focused approaches.

• Cancer Immunology
• Myeloid Cell Biology
• Tumor Microenvironment
• +۲ مورد دیگر

Robert C. Dunn is a Professor in the Department of Chemistry at the University of Kansas, specializing in analytical and physical chemistry. His research focuses on advanced microscopy techniques, membrane dynamics, and capillary electrophoresis innovations. Dunn holds a B.S. from California State University (1988), M.S. and Ph.D. from University of California, San Diego (1990, 1992), followed by postdoctoral work at Pacific Northwest Laboratory (1993-1995). Key research areas include single molecule spectroscopy, nuclear pore complex dynamics, and development of high-resolution optical methods like near-field scanning optical microscopy (NSOM) and scanning resonator microscopy (SRM). He pioneered high-speed capillary electrophoresis (HSCE) with back-scatter interferometry for rapid, label-free analysis. His lab explores lung surfactant stability and nuclear transport mechanisms, with applications in biomedical diagnostics and gene therapy. Awards include student recognition such as the Takeru Higuchi and John R. Shapley Awards. Dunn mentors graduate and undergraduate students in instrumentation development and biophysical studies. His work integrates advanced optical techniques with biological systems, published in journals like Science Reports , Analytical Chemistry , and ACS Photonics .

• Analytical Chemistry
• Biophysical Chemistry
• Nanotechnology
• +۵ مورد دیگر

Dr. Yuchen Li is an Assistant Professor currently appointed at Kingston General Hospital and Hotel Dieu Hospital. Their clinical focus includes Lung Cancer and Gastrointestinal Cancer, alongside interests in healthcare policy and quality improvement. Research spans artificial intelligence applications in healthcare and broader societal issues such as multicultural citizenship, animal rights, and social solidarity. Publications reflect interdisciplinary engagement with political theory, ethics, and policy reform. Education interests emphasize training medical students and residents, contributing to the development of future healthcare professionals. Their work critically examines topics like minority rights, devolution processes, and transformative approaches to animal protection, bridging clinical practice with theoretical exploration.

• Lung Cancer
• Gastrointestinal Cancer
• Healthcare Policy
• +۳ مورد دیگر

Severine Le Gac is a Full Professor at the University of Twente, affiliated with the TechMed Centre and leading the Applied Microfluidics for BioEngineering Research group. Her work bridges engineering and biomedical sciences through innovative microfluidic platforms. Her research interests focus on the development and application of microfluidic systems for bioengineering, particularly organ-on-chip technologies. These platforms enable precise control over cellular microenvironments for applications in disease modeling, drug testing, and fundamental biological studies. Key areas include fibrosis-on-chip, lung-on-chip, and advanced cell imaging substrates. The recent publications reflect a strong trend toward developing physiologically relevant in vitro models using microfabrication and hydrogel technologies. Her work integrates engineering design with biological functionality, emphasizing applications in toxicology, regenerative medicine, and high-resolution imaging. The research spans from fundamental device development to translational applications in human health. She actively contributes to the scientific community through invited talks and editorial roles, demonstrating leadership in the lab-on-a-chip field. Although specific grant details are not listed, her sustained research output and invited presentations suggest successful funding and collaborative engagement. Le Gac leads a research team focused on advancing microfluidic bioengineering solutions, contributing significantly to the TechMed Centre's mission of translating medical technology to clinical practice. Her group develops novel devices that mimic human organ functions for improved experimentation and therapeutic development.

• Microfluidics
• Organ-on-Chip
• Lab-on-a-Chip
• +۷ مورد دیگر

Barry Rockx is an Assistant Professor in the Department of Virology at Erasmus MC, where he conducts cutting-edge research on emerging and re-emerging RNA viruses. His work focuses on understanding viral pathogenesis, host immune responses, and developing advanced preclinical models to study infections such as SARS-CoV-2, Zika virus, West Nile virus, Usutu virus, and orthohantaviruses. His research interests span virology, immunology, and infectious diseases, with a particular emphasis on arboviruses and neurotropic viruses . He employs human lung xenograft mouse models and fetal organotypic brain slice cultures to investigate infection mechanisms and evaluate potential therapeutics. The recent publications (2024–2025) demonstrate a strong trend in studying vector-borne transmission , neurovirulence , and diagnostic development . His work frequently explores cross-viral comparisons (e.g., Usutu vs. Zika vs. West Nile), highlighting shared and distinct pathogenic mechanisms. Scientific contributions include: Development of a pan-orthohantavirus human lung xenograft model for preclinical testing Investigating mosquito saliva effects on West Nile virus pathogenesis Assessing neurotropism of Usutu and West Nile viruses in human neural tissues Implementing RT-PCR diagnostics for orthohantaviruses in endemic regions Dr. Rockx supervises research work, as indicated by the 'Supervised Work (4)' metric, suggesting mentorship of students or junior scientists. He collaborates widely across institutions and countries, contributing to a robust network in global virology research. There is no mention of formal education, awards, or grants in the provided text, but his publication record and active research profile underscore his significant role in advancing virological science.

• Virology
• Emerging Viral Infections
• Arbovirus Pathogenesis
• +۱۲ مورد دیگر

Dr. Maria Braoudaki is a Reader in Molecular Medicine at the University of Hertfordshire, UK. She holds a PhD in Molecular Microbiology from Aston University (2004) and an MSc in Molecular Medicine (with distinction) from the National and Kapodistrian University of Athens. Her research focuses on pediatric cancer genomics, epigenetics, and proteomics, with emphasis on microRNA profiling and high-throughput omics strategies. She has authored over 40 peer-reviewed publications and received prestigious awards, including the L’OREAL-UNESCO Award for Women in Science (2016) and recognition from the Cretan Scientists Association (2022). Research Projects: Cancer Management using AI (Co-Investigator, 2022–present) Apafix fixation for tissue analysis (Principal Investigator, 2022) Research Interests: MicroRNA-driven therapeutic strategies in pediatric and adult cancers Epigenetic regulation in oncogenesis Omics-based approaches for cancer diagnosis and prognosis Key Contributions: Pioneered work on microRNA signatures in medulloblastoma and glioblastoma Developed novel biomarker strategies for lung and colorectal cancers Explored extracellular vesicles as therapeutic delivery systems Grants & Collaborations: Lead investigator in Apafix fixation studies Co-Investigator in AI-driven cancer recurrence prediction (CaRPrAI, 2021–2022)

• Pediatric Cancer Genomics
• Genetics
• Epigenetics
• +۴ مورد دیگر

Dr. Axel W. E. Wismüller is a Professor of Radiology and Biomedical Engineering at the University of Rochester Medical Center . As Director of the AI Radiology Laboratory , he uniquely combines clinical practice in cardiothoracic/body imaging with pioneering research in Artificial Intelligence (AI) for medical imaging . Holding MD, MSc (Physics), and PhD (Electrical Engineering) degrees from German institutions, he maintains dual US and German medical licenses and board certifications. Ludwig-Maximilians-Universitaet München (1990-1996) Technical University of Munich (MD 1992, PhD 2006) Ludwig Maximilians University Munich (Residency 1997-2005) His research focuses on machine learning and network connectivity analysis in neuroimaging, particularly for HIV-associated neurocognitive disorders and multiple sclerosis . He invented the XOM algorithm (patented in US/EU) and developed AI systems for chest radiograph analysis , breast cancer imaging , and osteoporosis diagnostics . His work on large-scale Granger causality has transformed brain network analysis methodology. Scientific awards include SPIE Senior Membership (2016), NIH/NIDA R01 funding (2012-2015), and NYSTAR public-private partnerships . Supervising over 30 PhD/MSc students across engineering, computer science, and medicine , he bridges clinical and computational disciplines through active roles in ACR, RSNA, and SPIE .

• Artificial Intelligence in Radiology
• Machine Learning
• Health Informatics
• +۲ مورد دیگر

Salvador Borrós Gómez is a Full Professor and Director General at IQS School of Engineering, Universitat Ramon Llull, where he is affiliated with the Department of Chemical Engineering and Materials Science and the Bioengineering Department. He leads the GEMAT (Materials Engineering Group), a recognized research group in materials science and nanomedicine. His work bridges academic leadership, research innovation, and industrial collaboration. PhD in Chemical Engineering, IQS (1993) Bachelor in Materials Characterization, Universitat de Barcelona (1993) MBA, IQS (1993) Bachelor in Chemical Engineering, IQS (1987) His research focuses on functional polymeric materials , biomaterials , and nano-drug delivery systems , with applications in tissue engineering, cancer therapy, and sustainable materials. He has pioneered work in stimuli-responsive nanoparticles, smart surfaces, and 3D bioprinting of soft biomaterials. His research lines include the design of biomimetic surfaces, high-performance adhesives, and materials for fuel cells and rapid manufacturing. The most recent articles highlight a strong trend in nanomedicine , particularly in mRNA and siRNA delivery for cancer and genetic diseases, 3D printing of silicone-based soft materials , and advanced hydrogel systems for localized therapy. There is also significant work on pregnancy-safe nanotherapies and biomedical device innovation , reflecting a translational focus from lab to clinic. He has received no explicitly listed scientific awards in the provided texts, but his leadership in major research grants and high-impact publications suggests national and international recognition. Borrós has supervised multiple PhD students and research projects, including FPI fellowships and industrial collaborations. He has led or co-led major research initiatives such as 3D-CARTIBONE, RECYVAL, COVINANOVAX, and CERTERA, which involve interdisciplinary teams and significant external funding. His work emphasizes technology transfer and real-world impact. He leads the GEMAT research group, which is part of the TecnoCampus Maresme and affiliated with ACCIÓ’s Tecnio network. The group focuses on three pillars: new functional materials, surface engineering, and biomaterials. It is a fully consolidated research group (SGR) recognized by AGAUR and actively involved in both academic and industrial innovation.

• Materials Science
• Biomaterials
• Polymer Engineering
• +۱۶ مورد دیگر

Robin Patel, M.D., is a Professor of Medicine and Microbiology at Mayo Clinic in Rochester, Minnesota. She serves as Director of the Infectious Diseases Research Laboratory, Chair of the Division of Clinical Microbiology, and Director of the Bacteriology Laboratory within the Department of Laboratory Medicine and Pathology. Her work bridges clinical microbiology, infectious diseases, and translational research, with a focus on improving patient care through innovation in diagnostics and therapeutics. Her research interests center on biofilm-mediated infections , including prosthetic joint infections, endocarditis, and catheter-associated infections. She investigates mechanisms of biofilm formation and resistance, develops novel diagnostic assays, and evaluates new antimicrobial agents using in vitro and animal models (e.g., rabbit endocarditis, mouse pneumonia). Her lab is also deeply involved in combating antimicrobial resistance through innovative strategies such as electrochemical bandages and catheters. Dr. Patel's recent publications highlight trends in novel antimicrobial devices , phage therapy , proteomic analysis of biofilms , and advanced molecular diagnostics . Her work increasingly integrates engineering solutions with microbiology to create non-antibiotic interventions for persistent infections. Fellow, American Association for the Advancement of Science (2024) Distinguished Mayo Clinic Investigator (2022) Distinguished Educator Award (2021) Elizabeth P. and Robert E. Allen Professor of Individualized Medicine (2017) Fellow, American Academy of Microbiology (2012) Dr. Patel has led multiple NIH-funded grants, including projects on electrochemical catheters for bloodstream infection prevention and novel bandages for wound infections. She mentors a large research team and contributes significantly to national standards through leadership roles in the American Board of Pathology and Clinical and Laboratory Standards Institute. Her lab collaborates extensively across disciplines and institutions, driving innovation in clinical microbiology and infectious diseases. She is affiliated with key research centers at Mayo Clinic, including the Center for Individualized Medicine, the Infectious Diseases Research Center, and the Center for Clinical and Translational Science (CCaTS). Her laboratory is a hub for translational research, developing assays that are directly implemented in patient care at Mayo Clinic.

• Biofilm-mediated infections
• Clinical Microbiology
• Antimicrobial Resistance
• +۷ مورد دیگر

Nathan K. LeBrasseur, Ph.D., M.S. , is a Professor in the Department of Physical Medicine and Rehabilitation and the Department of Physiology at Mayo Clinic in Rochester, Minnesota. He holds key leadership roles including Director of the Robert and Arlene Kogod Center on Aging, Co-Director of the Mayo Clinic Paul F. Glenn Center for Biology of Aging Research, and Scientific Director of the Office of Translation to Practice. His work is central to advancing the science of aging and its clinical translation. Research Interests: Nathan K. LeBrasseur's research is dedicated to understanding the biological mechanisms of aging, with a focus on cellular senescence , skeletal muscle aging , and the development of biomarkers of biological age . His lab investigates how senescent cells contribute to physical decline, metabolic dysfunction, and frailty. A major focus is on how lifestyle factors, particularly exercise, can modulate the accumulation and clearance of senescent cells to promote resilience in older adults. Research Trends: His recent publications (2023–2025) demonstrate a strong trend towards translational and clinical research. The work spans from fundamental discoveries in cell biology (e.g., mtDNA release in senescence) to the characterization of human biomarkers for use in clinical trials. There is a clear emphasis on developing and validating tools to measure biological aging and on understanding the systemic impact of senescent cells on organs like muscle, bone, heart, and brain. His research increasingly leverages large cohort studies and aims to identify individuals who would benefit most from anti-aging interventions. Scientific Awards: Noaber Foundation Professor of Aging Research, Mayo Clinic (2024) Vincent Cristofalo Rising Star Award in Aging Research, American Federation for Aging Research (2019) Advising and Grants: Dr. LeBrasseur is a Principal Investigator (PI) on multiple major research grants, primarily from the National Institute on Aging (NIA). His funded projects include 'The Impact of Biological Mechanisms of Aging on Response Variability to Resistance Training in Older Adults (BRIO)' and the 'Biological Analysis Core.' He also serves as PI for the Vincent Cristofalo Rising Star Award and is a Co-PI on the Midwest Murine-Tissue Mapping Center. This extensive grant portfolio reflects his leadership in large-scale, collaborative aging research. Labs and Teams: Dr. LeBrasseur leads a research laboratory focused on the biology of aging at Mayo Clinic. His work is deeply integrated with major institutional centers, including the Robert and Arlene Kogod Center on Aging and the Mayo Clinic Paul F. Glenn Center. He is part of a large, collaborative network of scientists investigating cellular senescence, senolytics, and aging mechanisms, often co-authoring with leading figures in the geroscience field.

• Aging Biology
• Cellular Senescence
• Skeletal Muscle Aging
• +۷ مورد دیگر